Stay updated on IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.

Latest updates to the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry (v3.4.2) to the study history and removed the older funding-status notice. These are administrative updates that affect only the history display but not the study content.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and the NIH Clinical Center being open, and updated the study record with Revision: v3.4.1, while removing Revision: v3.4.0.SummaryDifference0.9%

- Check28 days agoChange DetectedThe Change History UI now includes a Show glossary option and green highlights for additions and red highlights for deletions, with version-tracking notes such as 'Revision: v3.4.0' and 'No FEAR Act Data'.SummaryDifference1%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history now includes Revision: v3.3.3. HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.